MONTREAL, April 25, 2013 /CNW Telbec/ - Valeo Management and its exclusive worldwide licensee FITTnLEAN, which markets Adipotronics, the patented targeted fat loss technology, announce the closing of a $1,000,000 investment by Partner One Capital.
The technology uses an electrical stimulator which induces targeted fat loss through a gentle electric current in areas designated by the user during physical activity. It was invented by researchers from the Departments of Kinanthropology and Biological Sciences of the University of Québec at Montréal (UQAM).
In 2012, FITTnLEAN successfully completed a 10 week triple-blind, randomized, placebo-controlled clinical study on the Adipotronics technology, showing impressive targeted fat loss results.
FITTnLEAN will be launching Adipotronics, the targeted fat loss technology, in late 2013.
FITTnLEAN is a Montreal company specializing in the development and commercialization of patented and/or innovative products and services in the areas of health, fitness and aesthetics. FITTnLEAN aims to become a leader in these areas, improve the well-being of users and influence trends and lifestyles. (www.fittnlean.com)
SOURCE: Gestion Valeo, s.e.c.
For further information:
Source : Valeo Management